Anne Wojcicki buys 23andme and his data for $ 305 million,
Health

Anne Wojcicki buys 23andme and his information for $ 305 million,

By UMass Mag

23Andme founder and board member Anne Wojcicki speaks on June 10, 2025 in Washington, DC.

Andrew Harnik | Getty pictures

Anne Wojcicki, the co-founder and former CEO of 23Andme, has control over the competitive genetic test company according to her new non-profit TTAM Research Institute, OUT BID Regeneron pharmaceuticalsThe company announced on Friday.

TTAM will essentially acquire all assets of 23Ande for $ 305 million, including the business limits for personal genome service and research services as well as the subsidiary of telemedicine subsidiary Lemonaid. It is a great victory for Wojcicki, who resigned from her role as CEO, when 23Andme submitted in March for insolvency protection in Chapter 11.

Last month, Regeneron announced that it would purchase most of the assets of 23 and 23ands for $ 256 million after it is ahead during an insolvency auction. But Wojcicki submitted a separate offer of 305 million US dollars via TTAM and urged to reopen the auction. According to Wall Street Journal, TTAM is an abbreviation for the first letters from 23Andme.

“I am thrilled that the TTAM research institute can continue the 23Andme mission to help people access, understand and benefit from human genome,” said Wojcicki in an explanation.

Due to his DNA test kits, 23Andme gained popularity at home, which gave customers an insight into their family history and genetic profiles. In 2021, the five -time CNBC Disruptor 50 Company went to the stock exchange with a merger with a special company for purposes. At its climax, 23Andme had a value of around 6 billion US dollars.

The company tried to generate recurring earnings and to face the public for viable research and therapists, and it was plagued by data protection concerns, since Hacker accessed the information from almost 7 million customers in 2023.

The acquisition of TTAM is still subject to the approval of the US insolvency court for the eastern district of Missouri.

REGARD: CEO des Regeneron CEO from 23Andme Bid: Attempt to reconcile the individual privacy with Biotech & Genetics Research

UMass Mag 10127 posts 0 comments

Jim Faile has done it all in his 27 year as an Author, Editor, Writer, Copywriter, Blogger, and Mentor. You name a newsroom beat and Jim has covered it with the best of them. He also loves his dogs, traveling, Rays baseball, and dreaming up his next writing project.

You might also like More from author

Comments are closed.